A Study YL201 in Patients With Selected Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study YL201 in Patients With Selected Advanced Solid Tumors	Advanced Solid Tumor	Active, not recruiting	Phase 1 / Phase 2	2026-03-12		NCT06057922

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
MediLink Therapeutics (Suzhou) Co., Ltd.	24

52 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital and Institute of Guangzhou Medical University	Guangzhou	China	6
Affiliated Cancer Hospital of Guangxi Medical University	Nanning	China	5
Affiliated Hospital of Chengde Medical University	Chengde	China	5
Affiliated Hospital of Jiangnan University	Wuxi	China	11
AnHui Provincial Cancer Hospital	Hefei	China	16
Chongqing University Cancer Hospital	Chongqing	China	33
Dongguan People's Hospital	Dongguan	China	23
First Affiliated Hospital of Gannan Medical University	Ganzhou	China	6
Fujian Cancer Hospital	Fuzhou	China	55
Harbin Medical University Cancer Hospital	Haerbin	China	3
Henan Cancer Hospital	Zhengzhou	China	98
Hunan Cancer Hospital	Changsha	China	87
Jiangmen Central Hospital	Jiangmen	China	11
Jiangxi Cancer Hospital (Jiangxi Second People's Hospital)	Nanchang	China	1
Jiangyin People's Hospital	Wuxi	China	2
Liaoning Cancer Hospital and Institute	Shenyang	China	2
Linyi Cancer Hospital	Linyi	China	22
Liuzhou People's Hospital	Liuzhou	China	12
Liuzhou Worker's Hospital	Liuzhou	China	6
Nantong Tumor Hospital	Nantong	China	7
Peking University People's Hospital	Beijing	China	44
Shandong Cancer Hospital and Institute	Jinan	China	8
Shandong Provincial Hospital	Jinan	China	24
Shanxi Cancer Hospital	Datong	China	1
Sichuan Cancer Hospital	Chengdu	China	30

Clinical trials